Clinical Trials Browser

Recruiting × OTHER × Lymphoma, T-Cell, Peripheral × Clear all

NCT07356245 2026-04-15

Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

Phase 2 Recruiting

DermatologicLymphoidOther hematologic neoplasm

Graft vs Host Disease, Leukemia, Lymphoma, Leukemia, Prolymphocytic, T-Cell, Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT06176690 2026-04-13

CABAL2

Phase 1 Recruiting

Hodgkin Disease, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic

NCT06508463 2026-04-13

Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma

Phase 1 Recruiting

Mycosis Fungoides, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic

NCT04512534 2026-04-02

Sincerely20

Phase 2 Recruiting

Lymphoma, T-Cell, Peripheral

NCT07300514 2026-03-31

T-START-M1

Phase 3 Recruiting

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Peripheral

NCT06519526 2026-03-24

Exploratory Clinical Study of SHR-0302 and SHR-2554 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma

Phase 2 Recruiting

Lymphoma, T-Cell, Peripheral

NCT07270861 2026-03-24

Real-world Outcomes of Peripheral T-cell Lymphoma: A Multicenter Retrospective and Prospective Cohort Study

Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

NCT07164560 2026-03-17

Exploratory Study of Umbilical Cord Blood-Derived CAR-NK Cell Therapy Targeting TRBC1/2 for Relapsed/Refractory T-Cell Lymphoma

Phase 1 Recruiting

Recurrence, Lymphoma, T-Cell, Peripheral

NCT07470996 2026-03-13

T-START-NR

Lymphoma, T-Cell, Peripheral

NCT07414758 2026-02-24

T-START-M1

Phase 3 Recruiting

Lymphoma, T-Cell, Peripheral

NCT06131801 2026-02-18

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

LymphoidMyeloidOther hematologic neoplasm

Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06630091 2026-02-17

A Phase II, Single-center, Single-arm Study Evaluating the Safety and Efficacy of Golidocitinib in the Management of Newly Diagnosed Peripheral T Cell Lymphoma Patients (GOLDEN Study) and Correlative Study

Phase 2 Recruiting

Lymphoma, T-Cell, Peripheral

NCT07389616 2026-02-05

A Clinical Trial of Cidabenamine Plus Azacitidine to Prevent Post-Transplant Progression in High-Risk Peripheral T-Cell Lymphoma

Phase 2/3 Recruiting

Lymphoma, T-Cell, Peripheral

NCT07353840 2026-01-20

T-START-CR

Pathologic Complete Response, Lymphoma, T-Cell, Peripheral

NCT07093710 2025-12-31

Golidocitinib Combined With Mitoxantrone Hydrochloride Liposome or Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma

Phase 1/2 Recruiting

Lymphoma, T-Cell, Peripheral

NCT07253129 2025-12-23

T-START-PR

Lymphoma, T-Cell, Peripheral

NCT07283822 2025-12-16

Amping up With PemJAK

Phase 2 Recruiting

DermatologicLymphoid

Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral

NCT07162012 2025-12-02

Anti-EBV TCR-T

Phase EARLY_PHASE1 Recruiting

Lymphoma, T-Cell, Peripheral, Lymphoma, Extranodal NK-T-Cell

NCT04083495 2025-09-22

CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma

Phase 2 Recruiting

Lymphoma, Lymphoma, T-Cell, Peripheral

NCT06160843 2025-09-05

POLAR

Phase 2 Recruiting

Lymphoma, T-Cell, Peripheral

NCT03719105 2025-08-08

Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma

Phase EARLY_PHASE1 Recruiting

LymphoidOther hematologic neoplasm

Lymphoma, T-Cell, Peripheral, Leukemia, Large Granular Lymphocytic

NCT04984837 2025-08-01

Study of Lacutamab in Peripheral T-cell Lymphoma

Phase 2 Recruiting

Recurrence, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

NCT07072221 2025-07-18

Bendamustine Combined With Chidamide and Lenalidomide for Relapsed and Refractory PTCL Patients

Phase NA Recruiting

Lymphoma, T-Cell, Peripheral

NCT06244368 2025-05-14

GVM±R in Patients With Relapsed or Refractory Aggressive NHL.

Phase 2 Recruiting

Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral

NCT03964480 2025-05-06

Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.

Lymphoma, T-Cell, Peripheral, Rare Diseases

NCT06914037 2025-04-06

COURAGE

Phase 1 Recruiting

DermatologicLymphoid

Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral

NCT05313243 2025-03-20

Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma

Phase 2 Recruiting

DermatologicLymphoid

Recurrence, Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral

NCT06855823 2025-03-04

A Phase I/II Study of Golidocitinib Combined with Pomalidomide in R/R PTCL

Phase 1/2 Recruiting

Recurrence, Lymphoma, T-Cell, Peripheral

NCT06151106 2025-02-19

Chidamide and Duvalisibon for the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma

Phase 2 Recruiting

Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

NCT05958719 2024-12-30

Chidamide in Combination With Azacitidine, Liposomal Mitoxantrone, and Prednisone (CAMP Regimen) for the Treatment of Previously Untreated Nodal TFH Cell Lymphoma

Phase 2 Recruiting

Lymphoma, T-Cell, Peripheral

NCT06739265 2024-12-18

Golidocitinib Plus CHOP in Newly Diagnosed PTCL

Phase 1/2 Recruiting

Lymphoma, T-Cell, Peripheral

NCT06176027 2024-10-29

Azacytidine Plus CAOLD Regimen in Relapsed/Refractory Peripheral T-Cell Lymphomas

Phase 1/2 Recruiting

Lymphoma, T-Cell, Peripheral

NCT04045470 2024-10-08

A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma

Phase NA Recruiting

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral

NCT06468267 2024-08-01

RIC With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory PTCL.

Phase 2 Recruiting

Lymphoma, T-Cell, Peripheral

NCT06509945 2024-08-01

Allo-PBSCT as the First-line Treatment for Patients With the High-risk PTCL

Phase NA Recruiting

Lymphoma, T-Cell, Peripheral

NCT06433362 2024-05-29

CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma

Phase 2 Recruiting

Lymphoma, T-Cell, Peripheral

NCT05949944 2024-05-17

Linperlisib in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma

Phase 1/2 Recruiting

Lymphoma, T-Cell, Peripheral

NCT05934864 2024-05-16

Different Molecular Subtypes of Peripheral T-cell Lymphoma, a Real-world Registry Study. (TRUST)

Lymphoma, T-Cell, Peripheral

NCT06362148 2024-04-22

CIRCULATE

Lymphoma, T-Cell, Peripheral, Lymphoma, Extranodal NK-T-Cell

NCT05675813 2024-01-08

THEORY

Phase 1/2 Recruiting

Lymphoma, T-Cell, Peripheral

NCT05444712 2023-09-28

TRANSCRIPT

Phase NA Recruiting

Lymphoma, T-Cell, Peripheral

NCT04922567 2022-11-07

Efficacy and Safety of Lenalidomide Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma

Phase 2 Recruiting

Lymphoma, T-Cell, Peripheral